May 14, 2002
Guidant to Acquire Biosensors'' Everolimus Eluting Stent Assets

Live Webcast Available

Indianapolis, Ind. - As previously announced, Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, will host a mid-quarter conference call on May 22, 2002 at 8:00 a.m. EDT.

The call will feature an update on Guidant's business, including an overview of the company's drug eluting stent program, endovascular solution business and a preview of the upcoming European Paris Course on Revascularization. Participating on the call will be Jay Graf, group chairman; Keith Brauer, vice president, finance and chief financial officer and John Capek, Ph.D., president, Vascular Intervention.

A live webcast of Guidant's conference call will be accessible through Guidant's website at www.guidant.com/webcast or at CCBN's individual investor center at www.companyboardroom.com. The webcast will be archived on both websites for future on-demand replay.

Guidant Corporation pioneers lifesaving technology, giving an opportunity for better life today to millions of cardiac and vascular patients worldwide. The company, driven by a strong entrepreneurial culture of more than 10,000 employees, develops, manufactures and markets a broad array of products and services that enable less invasive care for some of life's most threatening medical conditions.

System requirements for the webcast include Internet Explorer 5.0 (or higher) or Netscape Navigator 4.0 (or higher). Users also should have the most recent version of Windows Media Player, which can be downloaded for free at http://www.microsoft.com/windows/windowsmedia/en/download/. Users may experience varying levels of performance based on their connection speed, system capabilities and presence of a corporate firewall. To ensure a connection, users should go to the program five to 15 minutes before its start.